ClearPoint Neuro (CLPT) announced it has received 510 clearance for its ClearPoint Navigation Software Version 3.0. “As we prepare for the wave of new patients that will be treated with cell and ...

Lake Street analyst Frank Takkinen reiterated a Buy rating on ClearPoint Neuro (CLPT – Research Report) today. The company’s shares closed last Friday at $15.04. Takkinen covers the Healthcare ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...

AI is nervy. We know that a certain amount of Artificial Intelligence is somewhat nervy (or perhaps nervous) in its implementation because of concerns over decisioning bias, questions over the ...

Widespread neurological conditions, including Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, stroke, and brain tumors, are among the top causes of disability and death ...

Layering of Memories The neurological difference between your hesitant movements and the carpenter’s automatic behavior lies in the comparative strength of the “screwing memory.” This ...

In the movie, Raja Goutham plays a carefree youngster, who shares a quirky relationship with his grandfather, essayed by Brahmanandam. Written and directed by RVS Nikhil, the movie is set to hit ...

Neurological illnesses such as Alzheimer's disease (AD) and Parkinson's disease (PD) have long been difficult to study due to their complex pathophysiology and lack of effective therapies.

To help pay for tax breaks, for example, the congressional Republicans’ “menu” includes deep cuts to Medicaid, Medicare reimbursement policies, the Affordable Care Act, food stamps ...

A treatment that could potentially slow the progression of amyotrophic lateral sclerosis (ALS) is being studied at the Montreal Neurological Institute-Hospital. Dr. Olivier Blanchard and his team want ...